ArticleNPJ breast cancer2026

Racial differences in biomarkers, treatment, and outcomes in HR+/HER2- metastatic breast cancer in the United States.

Pegah Farrokhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.